Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
12 studies found for:    11583749 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
Condition: Chronic Hepatitis C
Interventions: Drug: Peg-IFN + WB RBV for 16 weeks;   Drug: Peg-IFN + LD RBV for 16 weeks;   Drug: Peg-IFN + WB RBV for 24 weeks;   Drug: Peg-IFN + WB RBV for 48 weeks;   Drug: Peg-IFN + LD RBV for 24 weeks
2 Unknown  Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy
Condition: Hepatitis
Intervention: Drug: Interferon Alfa-2b, Ribavirin
3 Recruiting Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Interferon Deficiency
Intervention: Drug: interferon alpha 2b
4 Completed Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9
Conditions: Chronic Hepatitis C;   Asian Americans;   Novel Genotypes;   Treatment
Intervention: Drug: Pegylated interferon and ribavirin
5 Unknown  4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B
Intervention: Drug: 4-Methylumbelliferone (Heparvit®)
6 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
7 Unknown  Reducing Depressive Symptoms During HCV Therapy: A Randomized Study
Conditions: Hepatitis C;   Depression
Intervention: Behavioral: Group Training
8 Unknown  12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
Condition: Hepatitis C
Intervention: Drug: UT-231B
9 Completed
Has Results
Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation
Condition: Hepatitis C
Intervention: Drug: LADR Treatment
10 Completed Trial of Peg-Interferon Plus Epoetin-Alfa for Treatment of Chronic Hepatitis C Virus Infection
Condition: Hepatitis C
Interventions: Drug: Peginterferon-alpha-2b (PEG-Intron);   Drug: Ribavirin;   Drug: Epoetin-alpha (Procrit)
11 Completed
Has Results
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Condition: Hepatitis C, Chronic
Intervention: Drug: Pegylated interferon alfa-2a plus ribavirin
12 Terminated Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: pegylated interferon alpha-2b;   Drug: Ribavirin;   Drug: pegylated Interferon alpha-2b

Indicates status has not been verified in more than two years